Study record managers: refer to the Data Element Definitions if submitting registration or results information.
|1||NCT03321981||Recruiting||MCLA-128 With Trastuzumab/Chemotherapy in HER2+ and With Endocrine Therapy in ER+ and Low HER2 Breast Cancer||
||Industry / Other||
||120||Female||18 Years and older (Adult, Older Adult)||NCT03321981||MCLA-128-CL02
|January 15, 2018||September 30, 2019||March 30, 2020||October 26, 2017||August 13, 2018||